Strategic Co-Investment Facility
A Nordic Women's Health Strategic Co-Investment Facility operating as pari-passu public co-investor at scale.
MoneyFemtech represents less than 1 % of digital health venture capital despite women being 50 % of the population. These guidelines recommend 50 % of health innovation funding targets women's health gaps — channelling Denmark's 160M DKK political will into sustained, systematic action.
Transformation
From
Nordic-built women's health innovation that scales to the global market currently leaves for US capital and US jurisdiction at the moment the science is ready; Oura's February 2026 redomiciliation is the worked example
To
A Nordic Women's Health Strategic Co-Investment Facility operating as pari-passu public co-investor with follow-on capacity and EIC-style strategic shareholder rights (consent over non-Nordic redomiciliation, change of control, transfer of core IP or data outside the Nordics) — operational within twelve months without new legislation, with FDI screening as case-by-case backstop
Description
A Nordic Women’s Health Strategic Co-Investment Facility would operate as a pari-passu public co-investor with follow-on capacity and EIC-style strategic shareholder rights, including consent over non-Nordic redomiciliation, change of control, and transfer of core IP or data assets outside the Nordics. Nordic-built women’s health innovation that scales to the global market currently leaves for US capital and US jurisdiction at the moment the science is ready. Oura’s February 2026 redomiciliation announcement is the case this named need addresses.
A Facility drawing on the EIC Fund strategic provisions template (279 portfolio companies, over EUR1.4 billion in signed investment, and over EUR1.6 billion in co-investment mobilised between 2021 and 2024), the Bpifrance French Tech Souveraineté envelope of EUR650 million, and Germany’s KfW Growth Fund, paired with Finnish Tesi’s industrial policy mandate and Swedish Almi Invest as ecosystem enablers, would let Nordic capital co-invest at the right stage with the right rights and keep women’s health-class assets in Nordic jurisdiction.
The Facility could be operational within twelve months without new legislation, with FDI screening as a case-by-case backstop. Nordic Innovation, the Nordic Investment Bank, and the five national investment instruments are positioned to design and launch it. The five instruments are Saminvest in Sweden, Tesi in Finland, EIFO in Denmark (the Export and Investment Fund formed in 2023 from Vækstfonden), Innovation Norway, and Rannís as Iceland’s research and innovation funding administrator.
Evidence anchors
At a glance
- Natural lead
- Nordic Innovation, Nordic Investment Bank, and five national investment instruments (Saminvest, Tesi, EIFO, Innovation Norway, Rannís)
- Indicative investment
- €0.5–1M (guideline development)
Entry points
- NordicNCM provides policy framework; Nordic Innovation promotes adoption
- NationalMinistries endorse guidelines; national agencies implement
- RegionalInnovation hubs apply guidelines to local funding
Indicators
Output
- Guidelines published with adoption toolkit
- All 5 countries at 50% allocation
- €500M+ annually in WH innovation funding
Handoff
- Funding agencies adopt reporting requirements
- Private co-investment increases
- Investment ecosystem self-sustaining
Outcome
- WH innovation funding visible and tracked
- Innovation pipeline grows measurably
Building on
Nordic foundations
European frameworks
Connected needs
Cite this need
Cite this need
Persson, J. (2026). I-M-1 Strategic Co-Investment Facility. In The Nordic Implementation Playbook for Women's Health 2040. CIFS. https://womenshealth2040.org/playbook#i-m-1